Drug Profile
6-Nitroquipazine
Latest Information Update: 21 Oct 1997
Price :
$50
*
At a glance
- Originator Research Biochemicals
- Developer Nonindustrial source; Research Biochemicals
- Class Hormones
- Mechanism of Action Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 21 Oct 1997 No-Development-Reported for Cancer in USA (Unknown route)
- 22 Sep 1995 New profile
- 22 Sep 1995 Preclinical development for Cancer in USA (Unknown route)